Investing in the Future of Healthtech

Health Innovation Pitch (HIP) brings together qualified startups with a community of healthcare-focused investors and industry advisors

The HIP Value

For Startups


Expedited process that provides an opportunity to present to multiple investors at the same time

Industry specific

Healthcare-only audience that can digest your value proposition right away

Fully managed process

End to end support for entire investment raise including quantified feedback at every step

For Investors

Highly curated opportunities

Healthcare-only deal flow that has been pre-screened by fellow investors

Community approach

Co-evaluate, collaborate and co-invest with investors and advisors with broad healthcare expertise

White glove service

From access, to due diligence to establishing the investment and advisory terms - we manage it all for you


Actively Funding and Advising

A clinically validated RPM platform to simplify diabetes and maximize patient provider workflows.

Actively Funding and Advising

Transforming cold cap therapy. Making cold caps affordable, easy to use, and effective for all solid tumor patients facing hair loss from chemotherapy.

Digital biomarker platform that measures “neurologic dysfunction” to digitally detect disease and drugs.

Technology platform with unified communications to quickly resolve all recall events.

Technology-enabled house calls: A platform empowering nurses and physicians to deliver advanced care in the comfort of patient’s home.

The world’s first empathetic voice companion for patients living with chronic disease.

Click here to learn how to apply to pitch at our next event

Investors and Advisors

aka HIPsters: healthcare-focused investors and industry advisors




Founder, Global Health Impact Fund

Gloria webster

Managing Director, Creekside Capital Ventures

amit aysola

Managing Director, Wanxiang Healthcare Investments

kamal gogineni

Co-Founder, Medneon

Dr. rakesh patel

Co-Founder, TME

yuri sudhakar

SVP, BioTelemetry

keith winter

Venture Partner, Teal Ventures

Click here to learn how to join our investor community


What they are saying


Chief Executive Officer at Diasyst

The investors we were put in front of, because they all understood healthcare, were not only very responsive, but also strategic in our growth.


Managing Partner, TME

HIP allows investors to stay on the cutting-edge of healthcare technology while providing companies the opportunity to hear unbiased feedback from seasoned leaders in the healthcare field—it’s a perfect fit.